NeuroMetrix
(NASDAQ:NURO)
$1.56
-0.05[-3.11%]
Last update: 2:07PM (Delayed 15-Minutes)
Get Real Time Here
Day Range1.53 - 1.5852 Wk Range1.35 - 7.41Open / Close1.57 / -Float / Outstanding7.7M / 7.8M
Vol / Avg.21K / 531.9KMkt Cap12.1MP/E-50d Avg. Price2.17
Div / Yield-Payout Ratio-Total Float7.7MEPS-0.23

NeuroMetrix Stock (NASDAQ:NURO), Quotes and News Summary

NeuroMetrix Stock (NASDAQ: NURO) stock price, news, charts, stock research, profile.

Loading...
Day Range1.53 - 1.5852 Wk Range1.35 - 7.41Open / Close1.57 / -Float / Outstanding7.7M / 7.8M
Vol / Avg.21K / 531.9KMkt Cap12.1MP/E-50d Avg. Price2.17
Div / Yield-Payout Ratio-Total Float7.7MEPS-0.23
Globe Newswire - Oct 20, 2022, 7:00AM
Globe Newswire - Jul 21, 2022, 7:00AM
Globe Newswire - Apr 26, 2022, 7:00AM
InvestorsObserver - Nov 10, 2022, 1:51PM
InvestorsObserver - Oct 20, 2022, 11:15AM
Seeking Alpha - Oct 13, 2022, 9:03AM
InvestorsObserver - Oct 12, 2022, 10:41AM
InvestorsObserver - Oct 11, 2022, 10:48AM
InvestorsObserver - Sep 14, 2022, 1:45PM
InvestorsObserver - Jun 1, 2022, 10:49AM
InvestorPlace - May 19, 2022, 2:39PM
InvestorsObserver - Apr 27, 2022, 6:55AM
Sector: Health Care.Industry: Health Care Equipment & Supplies
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment of being Medical equipment and consumables.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-01-26
REV
Q3 2022Est.ActualSurprise
EPS-0.230
REV1.968M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy NeuroMetrix (NURO) stock?

A

You can purchase shares of NeuroMetrix (NASDAQ: NURO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are NeuroMetrix's (NURO) competitors?

Q

What is the target price for NeuroMetrix (NURO) stock?

A

The latest price target for NeuroMetrix (NASDAQ: NURO) was reported by Rodman & Renshaw on Tuesday, June 28, 2016. The analyst firm set a price target for 4.50 expecting NURO to rise to within 12 months (a possible 188.46% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for NeuroMetrix (NURO)?

A

The stock price for NeuroMetrix (NASDAQ: NURO) is $1.56 last updated Today at November 28, 2022, 7:07 PM UTC.

Q

Does NeuroMetrix (NURO) pay a dividend?

A

There are no upcoming dividends for NeuroMetrix.

Q

When is NeuroMetrix (NASDAQ:NURO) reporting earnings?

A

NeuroMetrix’s Q4 earnings are confirmed for Thursday, January 26, 2023.

Q

Is NeuroMetrix (NURO) going to split?

A

There is no upcoming split for NeuroMetrix.

Q

What sector and industry does NeuroMetrix (NURO) operate in?

A

NeuroMetrix is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.